P1255: TUMOR-ASSOCIATED MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS IS A POTENTIAL PROGNOSTIC BIOMARKER, PROMOTING MULTI-DRUG RESISTANCE IN NHL PATIENTS BY MODULATING IL-6/IL-10/IL-1Β AXIS

• S. Dhar,
• M. Chakravarti,
• S. Bera,
• N. Ganguly,
• S. Dasgupta,
• A. Sarkar,
• A. Saha,
• S. Banerjee,
• B. Saha,
• R. Baral,
• K. K. Mukherjee,
• A. Bose

Affiliations

S. Dhar

1 IMMUNOREGULATION & IMMUNODIAGNOSTICS, CHITTARANJAN NATIONAL CANCER INSTITUTE, KOLKATA

M. Chakravarti

1 IMMUNOREGULATION & IMMUNODIAGNOSTICS, CHITTARANJAN NATIONAL CANCER INSTITUTE, KOLKATA

S. Bera

1 IMMUNOREGULATION & IMMUNODIAGNOSTICS, CHITTARANJAN NATIONAL CANCER INSTITUTE, KOLKATA

N. Ganguly

1 IMMUNOREGULATION & IMMUNODIAGNOSTICS, CHITTARANJAN NATIONAL CANCER INSTITUTE, KOLKATA

S. Dasgupta

1 IMMUNOREGULATION & IMMUNODIAGNOSTICS, CHITTARANJAN NATIONAL CANCER INSTITUTE, KOLKATA

A. Sarkar

1 IMMUNOREGULATION & IMMUNODIAGNOSTICS, CHITTARANJAN NATIONAL CANCER INSTITUTE, KOLKATA

A. Saha

1 IMMUNOREGULATION & IMMUNODIAGNOSTICS, CHITTARANJAN NATIONAL CANCER INSTITUTE, KOLKATA

S. Banerjee

1 IMMUNOREGULATION & IMMUNODIAGNOSTICS, CHITTARANJAN NATIONAL CANCER INSTITUTE, KOLKATA

B. Saha

2 Pathogenesis & Cell Responses, NCCS, Pune, Pune

R. Baral

1 IMMUNOREGULATION & IMMUNODIAGNOSTICS, CHITTARANJAN NATIONAL CANCER INSTITUTE, KOLKATA

K. K. Mukherjee

3 Medical Oncology, CHITTARANJAN NATIONAL CANCER INSTITUTE, KOLKATA, India

A. Bose

1 IMMUNOREGULATION & IMMUNODIAGNOSTICS, CHITTARANJAN NATIONAL CANCER INSTITUTE, KOLKATA